GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 676
EU - Europa 270
AS - Asia 243
AF - Africa 2
SA - Sud America 1
Totale 1.192
Nazione #
US - Stati Uniti d'America 666
SG - Singapore 140
IT - Italia 136
DE - Germania 52
ID - Indonesia 51
CN - Cina 43
PL - Polonia 20
GB - Regno Unito 16
FI - Finlandia 13
CA - Canada 10
SE - Svezia 10
CZ - Repubblica Ceca 4
NL - Olanda 4
IE - Irlanda 3
UA - Ucraina 3
BE - Belgio 2
DK - Danimarca 2
HK - Hong Kong 2
LT - Lituania 2
NG - Nigeria 2
RO - Romania 2
SY - Repubblica araba siriana 2
VN - Vietnam 2
BG - Bulgaria 1
BR - Brasile 1
IN - India 1
MY - Malesia 1
TR - Turchia 1
Totale 1.192
Città #
Chandler 127
Singapore 112
Santa Clara 91
Jakarta 50
Fairfield 45
Ashburn 41
Milan 34
Shanghai 31
Los Angeles 27
Addison 23
Bremen 21
Ferrara 21
Princeton 21
Warsaw 20
Munich 19
New York 15
Seattle 15
Cambridge 14
Bologna 12
Houston 12
Wilmington 12
Helsinki 10
San Diego 10
London 9
Woodbridge 9
Ann Arbor 7
Casalecchio Di Reno 7
Toronto 7
Modena 6
Frankfurt am Main 5
Boardman 4
Brno 4
Falkenstein 4
Treviso 4
Amsterdam 3
Chicago 3
Ferrara di Monte Baldo 3
Lappeenranta 3
Lusia 3
Voghera 3
Washington 3
Brussels 2
Cattolica 2
Dej 2
Des Moines 2
Dong Ket 2
Falls Church 2
Fermo 2
Gualtieri 2
Hong Kong 2
Lagos 2
Leawood 2
Naples 2
Norwalk 2
Ottawa 2
Parma 2
Redwood City 2
Rome 2
San Mateo 2
Santarcangelo di Romagna 2
Turin 2
Upper Darby 2
Baoding 1
Bengkulu 1
Boydton 1
Denton 1
Dublin 1
Forest City 1
Gambettola 1
Hangzhou 1
Huskvarna 1
Hyde 1
Jining 1
Manchester 1
Monmouth Junction 1
Mountain View 1
Odesa 1
Olbia 1
Pasadena 1
Philadelphia 1
Poggio Renatico 1
Salerno 1
Shijiazhuang 1
Sofia 1
Southwark 1
Stockholm 1
Tasek Gelugor 1
Wembley 1
Wenzhou 1
Yinchuan 1
Totale 940
Nome #
Functional hypothalamic and drug-induced amenorrhea: an overview 87
A tool to predict survival in stage IV entero-pancreatic NEN 75
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 68
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 56
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 56
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 48
Hypeprolactinemia: still an insidious diagnosis 45
Acromegaly in the elderly patients 44
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 42
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 40
Bone health in adolescence 38
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 37
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 37
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 34
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 34
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 34
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 34
Iperprolattinemia: vecchie e nuove insidie diagnostiche 30
I livelli di colesterolo LDL sono associati alla secrezione insulinica 30
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 29
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 28
Craniopharyngioma and Eating Disorders 28
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 28
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 27
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 27
L’acromegalia nell’anziano 26
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 25
Long-term low-dose tolvaptan efficacy and safety in SIADH 22
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 21
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 21
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 20
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 18
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 17
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 15
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 14
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 12
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 12
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 11
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 11
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 10
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) 4
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 1
Totale 1.296
Categoria #
all - tutte 14.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 417
Totale 14.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 4 4 6 4 4 0 2 0
2020/202192 0 11 1 9 11 5 4 9 9 18 8 7
2021/2022166 9 4 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/2025378 43 50 96 52 137 0 0 0 0 0 0 0
Totale 1.296